CLINICAL_TRIALS
trial_result
· 2020-01-03
Clinical Trial Update: A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease [Phase 2]
Summary
Phase 2 trial update for pirfenidone in unclassifiable progressive fibrosing interstitial lung disease completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Lung Diseases, Interstitial | Phase 2 | Status: COMPLETED | Results posted: 2020-01-03